Impact of Baseline Thrombocytopenia on Bleeding and Mortality After Percutaneous Coronary Intervention

被引:36
作者
Ito, Shinya [1 ]
Watanabe, Hirotoshi [2 ]
Morimoto, Takeshi [3 ]
Yoshikawa, Yusuke [2 ]
Shiomi, Hiroki [2 ]
Shizuta, Satoshi [2 ]
Ono, Koh [2 ]
Yamaji, Kyohei [1 ]
Soga, Yoshimitsu [1 ]
Hyodo, Makoto [1 ]
Shirai, Shinichi [1 ]
Ando, Kenji [1 ]
Horiuchi, Hisanori [4 ]
Kimura, Takeshi [1 ]
机构
[1] Kokura Mem Hosp, Div Cardiol, Kitakyushu, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan
[3] Hyogo Coll Med, Dept Clin Epidemiol, Nishinomiya, Hyogo, Japan
[4] Tohoku Univ, Inst Dev Aging & Canc, Dept Mol & Cellular Biol, Sendai, Miyagi, Japan
关键词
DUAL ANTIPLATELET THERAPY; ACUTE MYOCARDIAL-INFARCTION; EVEROLIMUS-ELUTING STENT; RANDOMIZED EVALUATION; HARMONIZING OUTCOMES; POOLED ANALYSIS; TRIAL; MANAGEMENT; REVASCULARIZATION; IMPLANTATION;
D O I
10.1016/j.amjcard.2018.02.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is still controversial whether baseline thrombocytopenia is independently associated with adverse events after percutaneous coronary intervention. We evaluated the influence of baseline thrombocytopenia against ischemic, bleeding and mortality among the 19,353 patients whose baseline platelet counts were available in the pooled database from the 3 studies in Japan. Baseline thrombocytopenia was classified as follows: mild, >= 100 and <150 x 10(9)/L; moderate, >= 50 and <100 x 10(9)/L; and severe, <50 x 10(9)/L. Primary ischemic outcome measure was defined as composite of myocardial infarction and ischemic stroke, and primary bleeding outcome measure was defined by the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded arteries trial as moderate or severe bleeding. There were 2,590 patients (13.4%) with baseline thrombocytopenia comprising 292 patients (1.5%) with moderate/severe (moderate: 277 and severe: 15) thrombocytopenia and 2,298 patients (11.9 %) with mild thrombocytopenia, whereas 16,763 patients (86.6 %) had no thrombocytopenia. During 3-year follow-up, the adjusted risks of moderate/severe and mild thrombocytopenia relative to none were neutral for primary ischemic outcome (hazard ratio [HR] 1.07 [95% confidence interval [CI] 0.72 to 1.60], p = 0.74, and HR 0.93 [0.79 to 1.09], p = 0.37, respectively) but were significantly higher for primary bleeding outcome (HR 2.35 [1.80 to 3.08], p <0.001, and HR 1.20 [1.03 to 1.40], p = 0.02), and for mortality (HR 2.34 [1.87 to 2.93], p <0.001, and HR 1.26 [1.11 to 1.43], p <0.001). In conclusion, patients with baseline thrombocytopenia, even a mild one, had a higher risk of bleeding events and all-cause death, but not for ischemic events after percutaneous coronary intervention. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:1304 / 1314
页数:11
相关论文
共 21 条
[1]   Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention [J].
Campo, G. ;
Marchesini, J. ;
Fileti, L. ;
Tebaldi, M. ;
Ferrari, R. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (01) :153-156
[2]   Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials [J].
Costa, Francesco ;
van Klaveren, David ;
James, Stefan ;
Heg, Dik ;
Raber, Lorenz ;
Feres, Fausto ;
Pilgrim, Thomas ;
Hong, Myeong-Ki ;
Kim, Hyo-Soo ;
Colombo, Antonio ;
Steg, Philippe Gabriel ;
Zanchin, Thomas ;
Palmerini, Tullio ;
Wallentin, Lars ;
Bhatt, Deepak L. ;
Stone, Gregg W. ;
Windecker, Stephan ;
Steyerberg, Ewout W. ;
Valgimigli, Marco .
LANCET, 2017, 389 (10073) :1025-1034
[3]   Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention [J].
Genereux, Philippe ;
Giustino, Gennaro ;
Witzenbichler, Bernhard ;
Weisz, Giora ;
Stuckey, Thomas D. ;
Rinaldi, Michael J. ;
Neumann, Franz-Josef ;
Metzger, D. Christopher ;
Henry, Timothy D. ;
Cox, David A. ;
Duffy, Peter L. ;
Mazzaferri, Ernest ;
Yadav, Mayank ;
Francese, Dominic P. ;
Palmerini, Tullio ;
Kirtane, Ajay J. ;
Litherland, Claire ;
Mehran, Roxana ;
Stone, Gregg W. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (09) :1036-1045
[4]   Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: Analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial [J].
Hakim, Diaa A. ;
Dangas, George D. ;
Caixeta, Adriano ;
Nikolsky, Eugenia ;
Lansky, Alexandra J. ;
Moses, Jeffrey W. ;
Claessen, Bimmer ;
Sanidas, Elias ;
White, Harvey D. ;
Ohman, E. Magnus ;
Manoukian, Steven V. ;
Fahy, Martin ;
Mehran, Roxana ;
Stone, Gregg W. .
AMERICAN HEART JOURNAL, 2011, 161 (02) :391-396
[5]  
Harrell FE, 2015, SPRINGER SER STAT, P275, DOI 10.1007/978-3-319-19425-7_11
[6]   Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents 1-Year Outcomes from the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial (RESET) [J].
Kimura, Takeshi ;
Morimoto, Takeshi ;
Natsuaki, Masahiro ;
Shiomi, Hiroki ;
Igarashi, Keiichi ;
Kadota, Kazushige ;
Tanabe, Kengo ;
Morino, Yoshihiro ;
Akasaka, Takashi ;
Takatsu, Yoshiki ;
Nishikawa, Hideo ;
Yamamoto, Yoshito ;
Nakagawa, Yoshihisa ;
Hayashi, Yasuhiko ;
Iwabuchi, Masashi ;
Umeda, Hisashi ;
Kawai, Kazuya ;
Okada, Hisayuki ;
Kimura, Kazuo ;
Simonton, Charles A. ;
Kozuma, Ken .
CIRCULATION, 2012, 126 (10) :1225-+
[7]   Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan [J].
Kimura T. ;
Morimoto T. ;
Furukawa Y. ;
Nakagawa Y. ;
Kadota K. ;
Iwabuchi M. ;
Shizuta S. ;
Shiomi H. ;
Tada T. ;
Tazaki J. ;
Kato Y. ;
Hayano M. ;
Abe M. ;
Tamura T. ;
Shirotani M. ;
Miki S. ;
Matsuda M. ;
Takahashi M. ;
Ishii K. ;
Tanaka M. ;
Aoyama T. ;
Doi O. ;
Hattori R. ;
Tatami R. ;
Suwa S. ;
Takizawa A. ;
Takatsu Y. ;
Takahashi M. ;
Kato H. ;
Takeda T. ;
Lee J.-D. ;
Nohara R. ;
Ogawa H. ;
Tei C. ;
Horie M. ;
Kambara H. ;
Fujiwara H. ;
Mitsudo K. ;
Nobuyoshi M. ;
Kita T. .
Cardiovascular Intervention and Therapeutics, 2011, 26 (3) :234-245
[8]   Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation [J].
Kimura, Takeshi ;
Morimoto, Takeshi ;
Nakagawa, Yoshihisa ;
Tamura, Toshihiro ;
Kadota, Kazushige ;
Yasumoto, Hitoshi ;
Nishikawa, Hideo ;
Hiasa, Yoshikazu ;
Muramatsu, Toshiya ;
Meguro, Taiichiro ;
Inoue, Naoto ;
Honda, Hidehiko ;
Hayashi, Yasuhiko ;
Miyazaki, Shunichi ;
Oshima, Shigeru ;
Honda, Takashi ;
Shiode, Nobuo ;
Namura, Masanobu ;
Sone, Takahito ;
Nobuyoshi, Masakiyo ;
Kita, Toru ;
Mitsudo, Kazuaki .
CIRCULATION, 2009, 119 (07) :987-U120
[9]   2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery [J].
Levine, Glenn N. ;
Bates, Eric R. ;
Bittl, John A. ;
Brindis, Ralph G. ;
Fihn, Stephan D. ;
Fleisher, Lee A. ;
Granger, Christopher B. ;
Lange, Richard A. ;
Mack, Michael J. ;
Mauri, Laura ;
Mehran, Roxana ;
Mukherjee, Debabrata ;
Newby, L. Kristin ;
O'Gara, Patrick T. ;
Sabatine, Marc S. ;
Smith, Peter K. ;
Smith, Sidney C., Jr. .
CIRCULATION, 2016, 134 (10) :E123-E155
[10]   Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents [J].
Mauri, Laura ;
Kereiakes, Dean J. ;
Yeh, Robert W. ;
Driscoll-Shempp, Priscilla ;
Cutlip, Donald E. ;
Steg, P. Gabriel ;
Normand, Sharon-Lise T. ;
Braunwald, Eugene ;
Wiviott, Stephen D. ;
Cohen, David J. ;
Holmes, David R., Jr. ;
Krucoff, Mitchell W. ;
Hermiller, James ;
Dauerman, Harold L. ;
Simon, Daniel I. ;
Kandzari, David E. ;
Garratt, Kirk N. ;
Lee, David P. ;
Pow, Thomas K. ;
Lee, Peter Ver ;
Rinaldi, Michael J. ;
Massaro, Joseph M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (23) :2155-2166